Pamela J. Jensen

发表

Migrating keratinocytes express urokinase-type plasminogen activator.

P. Jensen, G. Lazarus, J. Baird, 1987, The Journal of investigative dermatology.

Cytokine-induced expression of transforming growth factor-alpha and the epidermal growth factor receptor in neonatal skin explants.

U. Rodeck, P. Jensen, S. Albelda, 1992, The Journal of investigative dermatology.

Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration.

P. Jensen, Y. Ando, Pamela J. Jensen, 1993, The Journal of investigative dermatology.

Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo.

R. Lavker, P. Jensen, R. M. Lavker, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Epidermal plasminogen activator is abnormal in cutaneous lesions.

P. Jensen, S. Lessin, G. Lazarus, 1988, The Journal of investigative dermatology.

Human epidermal plasminogen activator. Characterization, localization, and modulation.

P. Jensen, G. Lazarus, S. Morioka, 1985, Experimental cell research.

Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherin.

P. Jensen, M. Wheelock, Pamela J. Jensen, 1992, Experimental cell research.

A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.

P. Jensen, H. Mcneill, Helen McNeill, 1990, Cell regulation.

Plasminogen activator inhibitor type 2 in human corneal epithelium.

S. Orlin, B. Risse, R. M. Lavker, 1999, Investigative ophthalmology & visual science.

Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis

P. Jensen, D. Loskutoff, G. Lazarus, 1994, Histochemistry.

Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope.

P. Jensen, N. Schechter, Y. Ando, 1995, Experimental cell research.

Urokinase is a positive regulator of epidermal proliferation in vivo.

R. Lavker, P. Jensen, R. M. Lavker, 1999, The Journal of investigative dermatology.

mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.

D. Belin, P. Jensen, J. Vassalli, 1990, The Journal of investigative dermatology.

Tissue plasminogen activator in psoriasis.

D. Belin, P. Jensen, J. Vassalli, 1990, The Journal of investigative dermatology.